Eli Lilly's stock has seen significant activity, with some reports indicating the company is experiencing strong sales and confidence in its products. The company has also made a notable acquisition and has seen its stock rise substantially in recent years, with some outlets reporting a gain of 418% since 2021. However, there are conflicting reports about the company's connections to high-profile individuals and access to its obesity drug, with some outlets suggesting a link to a government official and others denying it.